SCHEMBL2843646

SCHEMBL2843646

COOC(=O)Oc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
ATM Q13315 2/20 0.44
USP2 O75604 1/20 0.44
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
ELANE P08246 1/20 0.42
CA4 P22748 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.41
KDM4E B2RXH2 2/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2317883 0.86 TDP1 (0.50) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL14378828 0.83 CES2 (0.50) ALDH1A1GAAHTTSMN1; SMN2CYP1A2
SCHEMBL27496383 0.82 HPGD (0.57) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL29250 0.82 HPGD (0.57) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL27352197 0.81 TDP1 (0.54) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL18073 0.81 TDP1 (0.54) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL9241160 0.81 TDP1 (0.54) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL9353455 0.81 TDP1 (0.54) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL9353461 0.81 TDP1 (0.54) MAPTALDH1A1L3MBTL1TDP1ATM
SCHEMBL5237061 0.81 ELANE (0.50) MAPTALDH1A1L3MBTL1TDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724110-B1 Multilayered articles and method of manufacture thereof SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-08-21 EP disclosed
US-8900693-B2 Polycarbonate compositions having infrared absorbance, method of manufacture, and articles prepared therefrom SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2014-12-02 US disclosed
EP-1907465-B1 POLYCARBONATE COMPOSITIONS HAVING INFRARED ABSORBANCE, METHOD OF MANUFACTURE, AND ARTICLES PREPARED THEREFROM SABIC INNOVATIVE PLASTICS IP (NL) 2014-07-23 EP disclosed
EP-1529632-B1 Multilayered articles and method of manufacture thereof SABIC INNOVATIVE PLASTICS IP (NL) 2012-09-05 EP disclosed
EP-2202063-A2 Multilayered articles and method of manufacture thereof Sabic Innovative Plastics IP B.V. (NL) 2010-06-30 EP disclosed
EP-1559743-B1 Infra-red radiation absorption articles and method of manufacturing thereof SABIC INNOVATIVE PLASTICS IP (NL) 2009-02-18 EP disclosed
EP-1996650-A2 FLAME RETARDANT POLYCARBONATE COMPOSITIONS HAVING GOOD TRANSPARENCY AND LOW HAZE, METHOD OF MANUFACTURE, AND ARTICLES PREPARED THEREFROM Sabic Innovative Plastics IP B.V. (NL) 2008-12-03 EP disclosed
US-7399571-B2 Multilayered articles and method of manufacture thereof GENERAL ELECTRIC COMPANY (US) 2008-07-15 US disclosed
EP-1907465-A2 POLYCARBONATE COMPOSITIONS HAVING INFRARED ABSORBANCE, METHOD OF MANUFACTURE, AND ARTICLES PREPARED THEREFROM General Electric Company (US) 2008-04-09 EP disclosed
WO-2008013579-A2 FLAME RETARDANT POLYCARBONATE COMPOSITIONS HAVING GOOD TRANSPARENCY AND LOW HAZE, METHOD OF MANUFACTURE, AND ARTICLES PREPARED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-01-31 WO disclosed
WO-2005087008-A2 BIOCIDAL COMPOSITIONS AND METHODS OF MAKING THEREOF GENERAL ELECTRIC COMPANY (US) 2005-09-22 WO disclosed
WO-2005087855-A1 BIOCIDAL COMPOSITIONS AND METHODS OF MAKING THEREOF GENERAL ELECTRIC COMPANY (US) 2005-09-22 WO disclosed
US-20050203237-A1 Biocidal compositions and methods of making thereof CITIBANK, N.A., AS COLLATERAL AGENT 2005-09-15 US disclosed
US-20050202100-A1 Biocidal compositions and methods of making thereof CITIBANK, N.A., AS COLLATERAL AGENT 2005-09-15 US disclosed
WO-2005075550-A1 INFRA-RED RADIATION ABSORPTION ARTICLES AND METHOD OF MANUFACTURE THEREOF GENERAL ELECTRIC COMPANY (US) 2005-08-18 WO disclosed
EP-1559743-A1 Infra-red radiation absorption articles and method of manufacturing thereof GENERAL ELECTRIC COMPANY (US) 2005-08-03 EP disclosed
US-20050165148-A1 Infra-red radiation absorption articles and method of manufacture thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2005-07-28 US disclosed
WO-2005053953-A1 MULTIWALL SHEETS AND METHODS FOR MANUFACTURING THEREOF GENERAL ELECTRIC COMPANY (US) 2005-06-16 WO disclosed
US-20050112331-A1 Multiwall sheets and methods for manufacturing thereof GENERAL ELECTRIC COMPANY 2005-05-26 US disclosed
EP-1529632-A1 Multilayered articles and method of manufacture thereof GENERAL ELECTRIC COMPANY (US) 2005-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050202100-A1 Biocidal compositions and methods of making thereof PIK3C3, PRKACG, PRKX MAPT 2975/4885ALDH1A1 695/4885L3MBTL1 1709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.